# Kylix Bio, Inc. — Form D

Kylix Bio, Inc. of DOVER, DE, a company, filed a Form D exempt-offering notice with the SEC on 2026-01-26. The offering totals $12.0M, of which $850K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2026-01-26
- Form: D
- Accession: 0002106870-26-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $12.0M
- Amount sold: $850K
- Remaining: $11.2M
- Minimum investment: $50K
- Investors: 5
- Date of first sale: 2026-01-15
- Revenue range: Decline to Disclose
- SEC file number: 021-571108

## Issuer

- Name: Kylix Bio, Inc.
- CIK: 0002106870
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2025
- Address: 8 THE GREEN, SUITE A, DOVER, DE, 19901
- Phone: 949-278-8398

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Madeleine F. Clarfield | Director | Dover, DE |
| Catherine P.W. Illingworth | Director | Dover, DE |
| Hunter P.W. Watts | Director | Dover, DE |
| Catherine P.W. Illingworth | Executive Officer | Dover, DE |

## More

- [CIK 2106870 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2106870&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002106870-26-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.